Read time: 2 minutes
By: McKesson Health Systems Editorial Team
Our most-downloaded content by health system teams in November 2023 includes an eBook discussing how PSAOs can help health systems achieve more and relieve administrative burdens, a second eBook outlining orphan drug strategies to help 340B health systems achieve more, and an informative Q&A session breaking down six important things to know ahead of the upcoming DIR fee changes set to take effect on January 1, 2024. Click our recommended reads to learn more on Prescribed Perspectives about how partnering with McKesson can help your health system achieve more.
eBook: Keeping Pace With Challenges for In-House Specialty Pharmacies
Our free eBook provides health systems with a comprehensive overview of PSAOs, including Atlas Specialty, McKesson's newest PSAO solution helping health systems achieve more by bridging the gap between payers and health system providers.
eBook: Orphan Drugs – a Growing Opportunity for Health Systems
Orphan drugs have been making headlines for decades — not only for bringing new treatment options to patients with rare conditions and diseases, but also for notoriously high costs that are rewriting the rules for pricing, discounts, and reimbursement.
In this eBook, we’ve curated key drivers, trends, and statistics to help health systems put today’s orphan drug issues into perspective.
Q&A: 60 Days Until DIR Changes Take Effect
With just 60 days until January 1, 2024 – when the CMS final rule prohibiting Medicare Part D plan sponsors and PBMs from retroactively assessing DIR fees on any claim submitted by pharmacies under Medicare Part D will go into effect – we recently sat down with one of our McKesson experts, Ram Arumugam, RPh, MBA, to ask six important questions about the upcoming DIR fee changes and how pharmacy and health systems leaders can prepare for January 1st.
Share
Post
Post
Email